Allogene Therapeutics, Inc. (ALLO) › Shares OutstandingAllogene Therapeutics, Inc. (ALLO) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2017: 26.25M2018: 121.48M2019: 124.27M2020: 140.47M2021: 142.62M2022: 144.44M2023: 168.64M2024: 212.21M2025: 229.41M229.41M2017Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY2025229.41M+8.1%2024212.21M+25.8%2023168.64M+16.8%2022144.44M+1.3%2021142.62M+1.5%2020140.47M+13.0%2019124.27M+2.3%2018121.48M+362.8%201726.25M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share